Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/14/2025

Antidepressant-Associated Vertigo

Introduction to Antidepressant-Associated Vertigo

  • The American Academy of Child and Adolescent Psychiatry notes that paroxetine, fluvoxamine, and sertraline are the antidepressants most commonly associated with vertigo, particularly during discontinuation, while venlafaxine among SNRIs has a higher risk of dizziness and vertigo as side effects 1
  • The American family physician reports that dizziness is among the most commonly reported adverse effects of SSRIs 2
  • The Annals of Internal Medicine states that all second-generation antidepressants (including SSRIs, SNRIs) can cause dizziness as a side effect 3
  • Approximately 63% of patients on second-generation antidepressants experience at least one adverse effect, with dizziness being among the common ones, according to the American family physician 2

Discontinuation Syndrome and Vertigo

  • Paroxetine is most strongly associated with discontinuation syndrome including vertigo, as reported by the American Academy of Child and Adolescent Psychiatry 1
  • Fluvoxamine is associated with discontinuation syndrome to a lesser extent than paroxetine, according to the American Academy of Child and Adolescent Psychiatry 1
  • Sertraline is also associated with discontinuation syndrome to a lesser extent, as noted by the American Academy of Child and Adolescent Psychiatry 1
  • Venlafaxine has been associated with discontinuation symptoms including vertigo, as reported by the American Academy of Child and Adolescent Psychiatry 1

SNRIs and Vertigo

  • Venlafaxine and duloxetine have higher rates of adverse effects compared to SSRIs, including dizziness and vertigo, according to the American family physician 2
  • Adverse effects of SNRIs include dizziness, which can manifest as vertigo, as reported by the American Academy of Child and Adolescent Psychiatry 1

Older Antidepressants and Vertigo

  • TCAs have higher discontinuation rates due to adverse effects compared to SSRIs (NNH 4-30 for TCAs vs 20-90 for SSRIs), as reported by the American family physician 2
  • MAOIs can cause dizziness and are associated with significant drug interactions that may exacerbate balance problems, according to the American Academy of Child and Adolescent Psychiatry 1

Mechanisms of Antidepressant-Associated Vertigo

  • Combining serotonergic medications can increase the risk of serotonin syndrome, which includes dizziness among its symptoms, as reported by the American Academy of Child and Adolescent Psychiatry 1

Prescribing Antidepressants with Vertigo Concerns

  • For patients at high risk of vertigo, consider citalopram/escitalopram which may have a lower propensity for discontinuation symptoms, as suggested by the American Academy of Child and Adolescent Psychiatry 1
  • When discontinuing SSRIs/SNRIs, implement gradual tapering rather than abrupt cessation to minimize vertigo and other discontinuation symptoms, as recommended by the American Academy of Child and Adolescent Psychiatry 1
  • For sertraline, a tapering duration of 10-14 days is recommended after long-term use, according to Praxis Medical Insights 4
  • Assess for dizziness/vertigo at each visit, especially after dose changes, as recommended by Praxis Medical Insights 4
  • Inform patients about the potential for vertigo, especially with paroxetine, fluvoxamine, and sertraline, as suggested by the American Academy of Child and Adolescent Psychiatry 1

Special Populations

  • Elderly patients are more susceptible to vertigo from antidepressants; preferred agents include citalopram, escitalopram, and sertraline, as reported by the American family physician 2